1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Plasma Therapy Market by Type, Source, Application, End User, Region - Global Forecast to 2021

Plasma Therapy Market by Type, Source, Application, End User, Region - Global Forecast to 2021

  • July 2016
  • 212 pages
  • ID: 4010940
  • Format: PDF
  • By MarketsandMarkets

Summary

Table of Contents

Search Inside

The plasma therapy market is expected to grow from USD 135.6 million in 2016 to USD 297.6 million by 2021, at a CAGR of 14.0% from 2016 to 2021. This market is segmented on the basis of type, source, application, end user, and region. The pure PRP segment of the plasma therapy type market is expected to grow at the highest CAGR during the forecast period. Growth in this segment is mainly attributed to the high success rate of pure PRP therapy, less recovery time, and increase in healthcare expenditure worldwide.

Based on source, the plasma therapy market is segmented into autologous and allogenic. The autologous source segment is estimated to account for the largest share of the plasma therapy market in 2016. Prevalence of orthopedic disorders and the need for development of new therapies will drive the growth of this segment.

Based on application, the plasma therapy market is segmented into dermatology, cardiac muscle injury, dental, nerve injury, and others. The orthopedic segment is further segmented into arthritis, chronic tendinitis, and bone repair & regeneration. Similarly, the dermatology segment is further segmented into androgenic alopecia and plastic surgery. The dermatology application segment is expected to grow at the highest CAGR from 2016 to 2021, owing to increase in the number of cosmetic procedures and prevalence of dermatological disorders such as androgenic alopecia.

Based on end user, the plasma therapy market is segmented into hospitals & clinics and research institutes. The hospitals & clinics segment is estimated to account for the largest share of the global plasma therapy market in 2016. Rise in healthcare spending has resulted in the increasing use of PRP in hospitals & clinics.

On the basis of region, the plasma therapy market is led by North America, followed by Europe, Asia-Pacific, and rest of the world. Major factors contributing to the growth of the plasma therapy market include high incidences of trauma, increase in healthcare expenditure, and access to medical insurance in the U.S. On the other hand, stringent regulatory policies and side-effects associated with PRP therapy are restraining the growth of this market.

The report provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition to this, the report also offers an overview of company profiles that comprise product portfolios, developments, and strategies adopted by market players to maintain and increase their shares in the market. The market research data, current market size, and forecast of the future trends will help key market players and new entrants to make necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to maintain their competitive position in the plasma therapy market.

Major players operating in the plasma therapy market include BioLife Plasma Services (U.S.), Cambryn Biologics LLC (U.S.), Biotest (Germany), CSL Ltd. (Australia), Grifols International S.A. (Spain), Kedrion S.p.A. (Italy), LFB (France), Bio Products Laboratory Ltd. (BPL) (U.K.), China Biologic Products, Inc. (China), and Octapharma (Switzerland).

Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below mentioned strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on product portfolios of top players in the plasma therapy market. The report analyzes the plasma therapy market on the basis of type, source, application, end user, and region.
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the plasma therapy market.
- Competitive Assessment: In-depth assessment of market strategies, geographic and business segments, and product portfolios of leading players in the plasma therapy market.
- Market Development: Comprehensive information about emerging markets; this report analyzes the market for various plasma therapy products across varied geographies.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the plasma therapy market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Primary Immune Deficiency (PID) - Pipeline Review, H2 2019

Primary Immune Deficiency (PID) - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Primary Immune Deficiency (PID) - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Primary Immune Deficiency (PID) - Pipeline Review, H2 2019, provides an ...

Retinoic Acid Receptor Beta - Pipeline Review, H2 2019

Retinoic Acid Receptor Beta - Pipeline Review, H2 2019

  • $ 3500
  • November 2019

Retinoic Acid Receptor Beta - Pipeline Review, H2 2019SummaryAccording to the recently published report ’Retinoic Acid Receptor Beta - Pipeline Review, H2 2019’; Retinoic Acid Receptor Beta (RAR Beta ...

Retinoic Acid Receptor Gamma - Pipeline Review, H2 2019

Retinoic Acid Receptor Gamma - Pipeline Review, H2 2019

  • $ 3500
  • November 2019

Retinoic Acid Receptor Gamma - Pipeline Review, H2 2019SummaryRetinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) pipeline Target constitutes close ...


ref:plp2016

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on